| For: | Lowell JA, Farber MJ, Sultan K. Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease. World J Gastroenterol 2024; 30(25): 3182-3184 [PMID: 39006384 DOI: 10.3748/wjg.v30.i25.3182] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i25/3182.htm |
| Number | Citing Articles |
| 1 |
Feng-Fei Wu, Lan Bai, Hui Yang, Wen-Ting Xie. New perspectives and prospects for the next generation of combination therapy in inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(5): 99462 doi: 10.3748/wjg.v31.i5.99462
|
| 2 |
M. Iborra, B. Botella, M. D. Martín‐Arranz, D. Ceballos, C. Martínez‐Pascual, A. Garrido, P. Varela, M. Moreta, E. Brunet‐Mas, Y. González‐Lama, E. Rodríguez‐González, M. Vicuña, J. P. Gisbert, I. Ordás, F. Argüelles‐Arias, J. Tosca‐Cuquerella, R. Vicente‐Lidón, M. Sierra‐Ausín, I. Rodríguez‐Lago, D. Martín‐Rodríguez, J. M. Paredes, B. Sicilia, I. García de la Filia, N. Jiménez, M. Barreiro‐de Acosta, E. Betoré, I. Ferrer‐Bradley, L. García‐Alles, J. M. Huguet, S. Castellet‐Farrús, M. J. García, A. Gutiérrez‐Casbas, Á. Ponferrada‐Díaz, L. Ramos, M. Calafat, I. Vera, C. Suárez‐Ferrer, E. Fernández‐Velado, S. Rodríguez‐Sánchez, A. Mínguez, A. Mancebo, J. Barrio, S. Lario, D. R. de La Cruz, Alejandro Hernández‐Camba, C. Rodríguez‐Gutiérrez, M. Chaparro, E. Ricart, L. Almenara‐Michelena, A. Balaguer, E. Domènech, P. Nos. Real‐World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry. United European Gastroenterology Journal 2026; 14(4) doi: 10.1002/ueg2.70223
|
| 3 |
Guillermo Arturo Cañadas-de la Fuente, Antonio M Caballero-Mateos. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management. World Journal of Gastroenterology 2024; 30(35): 3942-3953 doi: 10.3748/wjg.v30.i35.3942
|
| 4 |
Zi-Ning Zhang, Li-Xuan Sang. Dual-targeted treatment for inflammatory bowel disease: Whether fecal microbiota transplantation can be an important part of it. World Journal of Gastroenterology 2024; 30(36): 4025-4030 doi: 10.3748/wjg.v30.i36.4025
|
| 5 |
Fu-Shan Tang, Yan-Miao Liu, Hang Zhang, Mei Nie, Jia-Wang Yan. Strengths, weaknesses, opportunities, and threats analysis of combination therapy for inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(9): 100607 doi: 10.3748/wjg.v31.i9.100607
|
| 6 |
Yuan-Ben Wang, Li Chen, Feng-Shang Zhu. New advances in biologics and small molecule drugs for treatment of inflammatory bowel disease. World Chinese Journal of Digestology 2026; 34(7) doi: 10.11569/wcjd.v34.i7.562
|
| 7 |
Mei Kang, Daiyuan Tang, Wei Huang, Mingxia Zhou, Qiang Ma, Yining Lan, Deyi Chen, Ya Li, Bing Han. Emerging role of Itaconate in inflammatory bowel disease: From multitarget Immunometabolic mechanisms to therapeutic translation. International Immunopharmacology 2025; 166 doi: 10.1016/j.intimp.2025.115632
|